We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Article |  FREE
Hermann Faller, MD, PhD; Heinrich Bülzebruck, PhD; Peter Drings, MD; et al.
Arch Gen Psychiatry. 1999;56(8):756-762. doi:10.1001/archpsyc.56.8.756.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Research Letter  | 
Acquired Resistance of EGFR-Mutant Lung Cancer to a T790M-Specific EGFR Inhibitor Emergence of a Third Mutation (C797S) in the EGFR Tyrosine Kinase Domain
Helena A. Yu, MD; Shaozhou K. Tian, MD; Alexander E. Drilon, MD; et al.
JAMA Oncology
Viewpoint  | 
The Slippery Slope of Broadening Treatment Eligibility and Weak End Points Defending the Oligo in Oligometastatic Non–Small-Cell Lung Cancer
Howard (Jack) West, MD
JAMA Internal Medicine
Research Letter  | 
A Randomized Trial Testing US Food and Drug Administration “Breakthrough” Language
Tamar Krishnamurti, PhD; Steven Woloshin, MD, MS; Lisa M. Schwartz, MD, MS; et al.
JAMA Oncology
Review  | 
Hospitalizations During Systemic Therapy for Metastatic Lung Cancer A Systematic Review of Real World vs Clinical Trial Outcomes
Rebecca M. Prince, MBBS, FRACP; Eshetu G. Atenafu, MSc, PStat; Monika K. Krzyzanowska, MD, MPH, FRCPC